Company intelligence
CNS Pharmaceuticals, Inc.
Focused on developing innovative therapies for serious diseases in neurology and oncology
About CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals is a biotechnology company focused on developing innovative therapies for serious diseases in neurology and oncology. With an experienced executive team and a focus on high-value therapeutic opportunities, the Company is working to build a differentiated portfolio of therapies addressing significant unmet medical needs. CNS Pharmaceuticals is committed to advancing novel treatments that have the potential to improve patient outcomes while creating long-term value for patients and shareholders.
Verified activity
Signals from CNS Pharmaceuticals, Inc.
2 published signals
Presence & Recognition
CNS Pharmaceuticals, Inc. Chief Business Officer Dylan Wenke participated in a virtual investor segment titled What This Means.
Reported by CNS Pharmaceuticals, Inc.
Strategy & Corporate Development
CNS Pharmaceuticals, Inc. is actively delivering on its mandate to build a pipeline of assets that matter for patients.
Reported by Dylan W.